SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

CALC

Calcimedica Inc.
NASDAQHealth Care

Latest close: 1.04 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 16, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 30, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Sep 16, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record48836 flagged findings
Reported transactions (Form 4)80since Nov 1, 2024 · and 8 other holdings
Corporate events (8-K)30since Mar 3, 2023

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as GRAY.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-12share offering or dilution eventrecentOpen filing ↗
    “…Closing Date, the Company issued to the Lender a warrant to purchase 641,163 shares of common stock of the Company (the “Warrant”)…”
    +1 more passage from the same document
    • “…The Shelf Registration Statement permits the offering, issuance and sale of common stock, preferred stock, debt securities…”
  • 2026-05-12listing compliance noticerecentOpen filing ↗
    “…the Minimum Bid Price Requirement, which may be extended for an additional 180 days if, on the last day of the initial compliance…”
    +1 more passage from the same document
    • “…Listing Rule 5810(c)(3)(A), the Company has 180 calendar days following the date of the notice, or until September 14, 2026, to…”
  • 2026-05-12regulatory investigationrecentOpen filing ↗
    “…foreign regulatory authority to approve pending applications or supplements to approved applications filed by us, or suspension…”
  • 2026-05-12Department of Justice inquiryrecentOpen filing ↗
    “…jurisdictions, particularly to the United States, are subject to increased scrutiny from regulators, individual litigants, and…”
  • 2026-05-12merger or acquisition eventrecentOpen filing ↗
    “…in Delaware in October 2006, which survived the Merger as more fully described below. The CalciMedica Subsidiary entity was dissolved…”
    +1 more passage from the same document
    • “…was dissolved and combined with the Company as of December 31, 2024. Reverse Merger Transaction On March 20, 2023, Graybug Vision,…”
  • 2026-03-18listing compliance noticerecentOpen filing ↗
    “…may be eligible for an additional 180 calendar day compliance period if, on the last day of the initial compliance period, the…”
    +1 more passage from the same document
    • “…during this 180-day grace period. In the event the Company does not regain compliance with the Minimum Bid Price Requirement by…”
  • 2026-03-18reverse splitrecentOpen filing ↗
    “…of the Company’s common stock on The Nasdaq Capital Market and the Company’s common stock continues to trade on the Nasdaq…”
  • 2026-03-03share offering or dilution eventrecentOpen filing ↗
    “…more purchasers. We may distribute securities from time to time in one or more transactions: • at a fixed price or prices, which may…”
    +1 more passage from the same document
    • “…• on or through the facilities of the Nasdaq Capital Market or any other securities exchange or quotation or trading service on…”

8 older entries not shown

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Mar 18, 2026).

Deadline: Sep 9, 2026 · passed

  • stockholders' equity · Nasdaq, rule 5550(b)(2) · notice of Mar 13, 2026 · pending · deadline Sep 9, 2026 (text and rule agree) · first period expired; a second 180-day period may exist that is not on record
  • market value of listed securities · Nasdaq, rule 5550(b)(2) · notice of Mar 13, 2026 · pending · deadline Sep 9, 2026 (text and rule agree) · first period expired; a second 180-day period may exist that is not on record

Open the 8-K at the SEC

Reverse splits in 5 years

2 reverse splits in 5 years (1:14 on Mar 20, 2023, 1:5 on Aug 31, 2026) · 1:70 cumulative

The other times: of 247 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 189 lost more than half and 21 rose (243 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 488)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 16, 268-K ↗Current report · A senior executive left or was appointed new
  • Insider transaction · 5 Form 4 filingsshow all 5hide
  • Sep 30, 268-K ↗Current report · Other events
  • Sep 30, 26424B5 ↗Securities offering
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Sep 16, 268-K ↗Current report · Other events
  • Sep 2, 268-K ↗Current report · Other events
  • Aug 27, 268-K ↗Current report · Bylaws or fiscal year change
  • Aug 25, 26SCHEDULE 13G ↗Passive stake · Stonepine Capital Management, LLC · 6.0% · event on Aug 19, 26
  • Aug 24, 26Form 4 ↗Insider transaction
  • Aug 24, 26SCHEDULE 13D/A ↗Stake with intent to influence · Alafi Capital Company LLC · 19.9% · event on Aug 19, 26 · amendment
  • Insider transaction · 7 Form 4 filingsshow all 7hide

488 filings on record, the oldest from Aug 28, 20.

Listing the 25 most recent filings of the 488 on record.

8-Ks, explained

Stress8Structure16Governance14
  • Governance3 senior executive changes2026show all 3hide
    • Oct 16, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Aug 20, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jul 7, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jun 24, 26StructureSold unregistered shares+4 more in the same filing8-K 3.02 ↗
  • Jun 24, 26StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Mar 18, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jun 27, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jun 6, 25GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Mar 5, 25StructureTook on a new financial obligation+4 more in the same filing8-K 2.03 ↗
  • Jan 14, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Nov 8, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Oct 31, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Aug 27, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 10, 24GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗

6 older filings not shown · The record reaches back to Apr 18, 22.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • May 12, 23StressPast accounts declared unreliable and being restated8-K 4.02 ↗
  • May 5, 23StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Mar 22, 23StressListing notice (8-K 3.01)+8 more in the same filing8-K 3.01 ↗
  • Dec 28, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Aug 23, 22StressWrite-down of assets+1 more in the same filing8-K 2.06 ↗
  • Jun 21, 22StressListing notice (8-K 3.01)8-K 3.01 ↗

The full record holds 8 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Alafi Capital Company LLC19.9%Aug 19, 26SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Bering Partners II GP, L.L.C.10.0%Aug 19, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Eric W. Roberts6.4%Jun 25, 26SCHEDULE 13D/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Alafi Capital Company, LLC11.3%Jul 22, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Armistice Capital, LLC10.0%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Woodline Partners LP8.1%Jun 30, 26SCHEDULE 13G ↗
  • Chernett Jorey7.9%Nov 24, 25SCHEDULE 13G ↗
  • Stonepine Capital Management, LLC6.0%Aug 19, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 4 more holdershide
  • CVI Investments, Inc.5.1%Jun 23, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Avenue Venture Opportunities Fund II, L.P.5.0%Jun 23, 26SCHEDULE 13G/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Deerfield Mgmt, L.P.4.3%Feb 6, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Soleus Capital Management, L.P.2.4%Mar 31, 26SCHEDULE 13G/A ↗9 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Jun 25, 26Buy$200KFred A Middleton↗
  • Sep 18, 25Buy$8KEric W RobertsCHIEF BUSINESS OFFICER↗
  • Sep 15, 25Buy$9KEric W RobertsCHIEF BUSINESS OFFICER↗
  • Sep 12, 25Buy$16KEric W RobertsCHIEF BUSINESS OFFICER↗
  • Sep 9, 25Buy$7KEric W RobertsCHIEF BUSINESS OFFICER↗
  • Aug 29, 25Buy$2KEric W RobertsCHIEF BUSINESS OFFICER↗
  • Aug 28, 25Buy$26KEric W RobertsCHIEF BUSINESS OFFICER↗
  • Aug 21, 25Buy$10KEric W RobertsCHIEF BUSINESS OFFICER↗
  • Aug 20, 25Buy$5KEric W RobertsCHIEF BUSINESS OFFICER↗
  • Aug 19, 25Buy$27KSudarshan HebbarChief Medical Officer↗
  • Aug 19, 25Buy$3KEric W RobertsCHIEF BUSINESS OFFICER↗
  • Aug 15, 25Buy$12KSudarshan HebbarChief Medical Officer↗

There are 23 more transactions in this stretch.

Stock compensation, tax and giftsshow the 5 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jun 25, 26Compensation$950KROBERT N WILSON↗
  • Jun 25, 26Compensation$150KA. Rachel LehenyCHIEF EXECUTIVE OFFICER↗
  • Jun 25, 26Compensation$150KEric W RobertsCHIEF BUSINESS OFFICER↗
  • Jun 25, 26Compensation$100KSudarshan HebbarChief Medical Officer↗
  • Aug 20, 25Compensation$23KEric W RobertsCHIEF BUSINESS OFFICER↗

The full record holds 162 transactions and goes back to Mar 3, 23.

Its sector and its market

Calcimedica Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Calcimedica Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Calcimedica Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
488 documents on file, from Aug 28, 2020 to Oct 16, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.